A study on lung adenocarcinoma demonstrated that Lnc-FTX is upregulated in tumor tissues and accelerates malignant characteristics of Lung adenocarcinoma by activating the miR-335-5p/NUCB2 pathway 43. This evidence concerns the gene NUCB2 and lung adenocarcinoma.